Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis

Protein and Peptide Letters

Volumn 17, Issue 2, 2010, Pages 269-276

  Singh, Vijai ^a   Somvanshi, Pallavi ^b  

^a UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^b Bioinformatics Centre   (India)

Author keywords

Drugs; LigA; Mycobacterium tuberculosis; Phylogenetic tree

Indexed keywords

BACTERIAL PROTEIN; ENZYME INHIBITOR; ESCHERICHIA COLI PROTEIN; LIGA PROTEIN, E COLI; NICOTINAMIDE ADENINE DINUCLEOTIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE (NAD); TUBERCULOSTATIC AGENT;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; ENZYME ACTIVE SITE; ENZYMOLOGY; ESCHERICHIA COLI; HYDROGEN BOND; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DATABASE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; TUBERCULOSIS; VALIDATION STUDY;

AMINO ACID SEQUENCE; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; DNA LIGASES; DRUG DESIGN; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HYDROGEN BONDING; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; NAD; PHYLOGENY; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); LIGA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 77950010038     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610790225950     Document Type: Article

References (33)

1. Cohen, T.; Colijn, C.; Finklea, B.; Wright, A.; Zignol, M.; Pym, A.; Murray, M. Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study. PLoS ONE, 2008, 3(6), 2363.
2. Dahle, U.R.; Sandven, P.; Heldal, E.; Caugan, D.A. Continued low transmission of Mycobacterium tuberculosis in Norway. J. Clin. Microbiol., 2003, 41, 2968-2973.
3. Raviglione, M. XDR-TB: entering the post-antibiotic era. Int. J. Tuberc. Lung Dis., 2006, 10, 1185-1187.
4. Doherty, A. J.; Suh, S. W. Structural and mechanistic conservation in DNA ligases. Nucleic Acids Res., 2000, 28, 4051-4058.
5. Wilkinson, A.; Day J.; Bowater R. Bacterial DNA ligases. Mol. Microbiol., 2001, 40, 1241-1248.
6. Shuman, S.; Lima, C.D. The polynucleotide ligase and RNA cap-ping enzyme superfamily of covalent nucleotidyltransferases. Curr. Opin. Struct. Biol., 2004, 14, 757-764.
7. Tomkinson, A.E.; Vijayakumar, S.; Pascal, J.M.; Ellenberger, T. DNA ligases: structure, reaction mechanism, and function. Chem. Rev., 2006, 106, 687-699.
8. Chou, K.C.; Shen, H.B. Review: Recent progresses in protein sub-cellular location prediction. Anal. Biochem., 2007, 370, 1-16.
9. Chou, K.C.; Shen, H.B. Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nat. Protocols, 2008, 3, 153-162.
10. Wang, J.F.; Wei, D.Q.; Chen, C.; Li, Y.; Chou, K.C. Molecular modeling of two CYP2C19 SNPs and its implications for personal-ized drug design. Protein Pept. Lett., 2008, 15, 27-32.
11. Wang, J.F.; Wei, D.Q.; Li, L.; Zheng, S.Y.; Li, Y.X.; Chou, K.C. 3D structure modeling of cytochrome P450 2C19 and its implica-tion for personalized drug design. Biochem. Biophys. Res. Commun. (Corrigendum: ibid, 2007, Vol. 357, 330), 2007, 355, 513-519.
12. Du, Q.S.; Wei, Y.T.; Pang, Z.W.; Chou, K.C.; Huang, R.B. Predict-ing the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction. Protein Eng, Des. Select., 2007, 20, 417-423.
13. Chou, K.C.; Watenpaugh, K.D.; Heinrikson, R.L. A Model of the complex between cyclin-dependent kinase 5(Cdk5) and the activa-tion domain of neuronal Cdk5 activator. Biochem. Biophys. Res. Comm, 1999, 259, 420-428.
14. Chou, K.C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.
15. Chou, K.C.; Wei, D.Q.; Zhong, W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (Erratum: ibid., 2003, Vol. 310, 675). Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
16. Singh, V.; Somvanshi, P. Inhibition of oligomerization of aerolysin from Aeromonas hydrophila: homology modeling and docking ap-proach for exploration of hemorrhagic septicemia. Lett. Drug Des. Discov., 2009, 6(3) 215-223.
17. Singh, V.; Somvanshi, P.; Rathore, G.; Kapoor, D.; Mishra, B.N. Gene cloning, expression and homology modelling of hemolysin gene from Aeromonas hydrophila. Protein Exp. Purif., 2009, 27(1), 1-7.
18. Somvanshi, P.; Singh, V. Homology modeling and prediction of catalytic amino acid in the neurotoxin from Indian cobra (Naja naja). Open Bioinform. J., 2008, 2, 97-102.
19. Altschul, S.F.; Thomas, L.M.; Alejandro, A.S.; Jinghui, Z.; Zheng, Z.; Miller, W.; Lipman, D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 1997, 25, 3389-3402.
20. Sali, A.; Blundell, T.L. Comparative protein modeling by satisfaction of spatial restrains. J. Mol. Biol., 1993, 234, 779-815.
21. Delano, W.L. The PYMOL molecular graphics system. DeLano Scientific, Palo Alto, CA, 2002.
22. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: a program to check the stereochemical quality of protein structure. J. Appl. Crystallogr., 1993, 26, 283-291.
23. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. Automated docking using a La-marckian genetic algorithm and an empirical binding free energy function. J. Comp. Chem., 1998, 19, 1639-1662.
24. Thompson, J.D.; Gibson, T.J.; Plewniak, F.; Jeanmougin, F.; Hig-gins, D.G. The CLUSTALX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res., 1997, 25, 4876-4882.
25. Tamura, K.; Dudley, J.; Nei, M.; Kumar, S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 2007, 24, 1596-1599.
26. Jeong, K.W.; Lee, J.Y.; Kim, Y. Homology modeling and docking study of beta-ketoacyl acy carrier protein synthase III from Enterococcus faecalis. Bull. Korean Chem. Soc., 2007, 28(8), 1335-1340.
27. +-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I. Nucleic Acids Res., 2005, 33, 7090-7101.
28. Chatterji, M.; Unniraman, S.; Mahadevan, S.; Nagaraja, V. Effect of different classes of inhibitors on DNA gyrase from Mycobacte-rium smegmatis. J. Antimicrob. Chemother., 2001, 48, 479-85.
29. Schnell, J.R.; Chou, J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 2008, 451, 591-595.
30. Huang, R.B.; Du, Q.S.; Wang, C.H.; Chou, K.C. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem. Biophys. Res. Comm., 2008, 377, 1243-1247.
31. +-dependent DNA ligase by pyridochromanones. J. Biol. Chem., 2003, 278, 39435-39442.
32. Singh, V.; Somvanshi, P. Homology modeling of 3-oxoacyl-acyl carrier protein synthase II (KAS II) from Mycobacterium tubercu-losis H37Rv and molecular docking for exploration of drugs. J. Mol. Mod., 2009, 15(5), 453-460.
33. +-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor. Proteins, 2007, 69(1), 97-111.